Home > Insider Trading > Filing (0000950170-24-071532)

Filing Details

Accession Number:: 0000950170-24-071532
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-06-10 19:38:44
Reporting Period:: 2024-06-10

Accepted Time:: 2024-06-10 19:38:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
2012593	Rapport Therapeutics Inc.	RAPP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1245624	James Healy	Rapport Therapeutics, Inc. 1325 Boylston Street, Suite 401 Boston MA 02215		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-06-10	1,392,738	$0.00	1,392,738	No	4	C	Indirect	By Sofinnova Venture Partners XI, L.P.
Common Stock	Acquisiton	2024-06-10	470,589	$17.00	1,863,327	No	4	P	Indirect	By Sofinnova Venture Partners XI, L.P.
Common Stock	Acquisiton	2024-06-10	18,641	$17.00	18,641	No	4	P	Indirect	By Sofinnova Synergy Master Fund LP
Common Stock	Acquisiton	2024-06-10	17,861	$17.00	17,861	No	4	P	Indirect	By Crestline Summit Master, SPC - CRESTLINE SUMMIT APEX SP
Common Stock	Acquisiton	2024-06-10	26,278	$17.00	26,278	No	4	P	Indirect	By Crestline Summit Master, SPC - PEAK SP
Common Stock	Acquisiton	2024-06-10	25,455	$17.00	25,455	No	4	P	Indirect	By CRESTLINE SUMMIT PINNACLE MASTER, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Sofinnova Venture Partners XI, L.P.
No	4	P	Indirect	By Sofinnova Venture Partners XI, L.P.
No	4	P	Indirect	By Sofinnova Synergy Master Fund LP
No	4	P	Indirect	By Crestline Summit Master, SPC - CRESTLINE SUMMIT APEX SP
No	4	P	Indirect	By Crestline Summit Master, SPC - PEAK SP
No	4	P	Indirect	By CRESTLINE SUMMIT PINNACLE MASTER, L.P.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2024-06-10	11,924,138	$0.00	1,392,738	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

Upon the closing of the Issuer's initial public offering, each share of Series B Preferred Stock automatically converted into Common Stock on a one-for-8.5648 basis without payment of consideration. The Series B Preferred Stock had no expiration date.
The shares are directly held by Sofinnova Venture Partners XI, L.P. ("SVP XI"). Sofinnova Management XI, L.P. ("SM XI LP") is the general partner of SVP XI and Sofinnova Management XI, L.L.C. ("SM XI") is the general partner of SM XI LP. The Reporting Person is a managing member of SM XI and may be deemed to share voting and dispositive power over the shares held by SVP XI. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
The shares are directly held by Sofinnova Synergy Master Fund LP ("Synergy Fund"). Sofinnova Synergy GP, LLC ("Synergy Fund GP") is the general partner of Synergy Fund. The Reporting Person is a managing member of Synergy Fund GP and may be deemed to share voting and dispositive power over the shares held by Synergy Fund. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
The shares are directly held by Crestline Summit Master, SPC - CRESTLINE SUMMIT APEX SP ("APEX SP"). Synergy Fund GP is the general partner of APEX SP. The Reporting Person is a managing member of Synergy Fund GP and may be deemed to share voting and dispositive power over the shares held by APEX SP. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
The shares are directly held by Crestline Summit Master, SPC - PEAK SP ("PEAK SP"). Synergy Fund GP is the general partner of PEAK SP. The Reporting Person is a managing member of Synergy Fund GP and may be deemed to share voting and dispositive power over the shares held by PEAK SP. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
The shares are directly held by CRESTLINE SUMMIT PINNACLE MASTER, L.P. ("Pinnacle LP"). Synergy Fund GP is the general partner of Pinnacle LP. The Reporting Person is a managing member of Synergy Fund GP and may be deemed to share voting and dispositive power over the shares held by Pinnacle LP. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.